Published on
Dec 12, 2025
Shore Capital hails improved US biotech funding environment for hVIVO
"The funding environment for biotech has been at a lull relative to the heights that were enjoyed leading up to and throughout the pandemic," Shore Capital said. "However, on Wednesday this week, eight separate US biotechs raised cumulative …
Source:
ShareCast
-
Neutral
